Fovista (pegpleranib) - Iveric bio, Novartis, Roche
Ophthotech: Investor Day (IVERIC bio) - Jan 2, 2016 - “OPH1005 Study: Anti-Fibrosis Study”; “Visual Outcome Over Time”; “6 Patients Have Month 14 Values” 
P2a data • Ophthalmology
http://edge.media-server.com/m/p/rkrqbsvw
 
Jan 2, 2016
 
.